S.1425: Stop STALLING Act

About This Bill

Bill Versions

Bill Summary

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with S.1425.

Bill Actions

Date Description
Dec. 8, 2021
Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
Dec. 8, 2021
Committee on the Judiciary. Reported by Senator Durbin without amendment. Without written report.
July 29, 2021
Committee on the Judiciary. Ordered to be reported without amendment favorably.
April 28, 2021
Read twice and referred to the Committee on the Judiciary.
April 28, 2021

Introduced in the Senate by Amy Klobuchar (D-Minn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page